BioRestorative Therapies Inc
Research BioRestorative Therapies Inc (BRTX) on Bullrun: market cap USD 48.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBRTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 48.66M
- Financial periodQ1 2026
- RevenueUSD 23.17K
- Net income-USD 2.15M
- Free cash flow-USD 3.81M
- Gross margin68.1%
Valuation Snapshot
latest market cap is USD 48.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 359.70K | -USD 14.24M | -USD 10.91M | 93.4% | -1.58 | USD 1.51M | n/a | USD 356.74K |
| FY2024 | USD 401.00K | -USD 8.98M | -USD 8.34M | 93.0% | -1.16 | USD 547.89K | USD 0 | USD 8.53M |
| FY2023 | USD 145.80K | -USD 10.42M | -USD 6.60M | 100.0% | -2.47 | USD 884.38K | USD 162.32K | USD 10.00M |
| FY2022 | USD 119.80K | -USD 13.22M | -USD 6.18M | n/a | -3.65 | USD 1.71M | USD 301.65K | USD 10.29M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 48.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 10.39M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.90M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 8.19M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 10.10M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 15.28M | n/a | n/a | n/a |
About BioRestorative Therapies Inc
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BioRestorative Therapies Inc's market cap?
BioRestorative Therapies Inc's market capitalization is USD 48.66M.
What does BioRestorative Therapies Inc do?
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders.